Cover Image

α-1 Antitrypsin Inhibits RANKL-induced Osteoclast Formation and Functions

Abstract Osteoporosis is a global public health problem affecting more than 200 million people worldwide. We previously showed that treatment with α-1 antitrypsin (AAT), a multifunctional protein with antiinflammatory properties, mitigated bone loss in an ovariectomized mouse model. However, the und...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mohammad Ahsanul Akbar (Author), David Nardo (Author), Mong-Jen Chen (Author), Ahmed S. Elshikha (Author), Rubina Ahamed (Author), Eslam M. Elsayed (Author), Claire Bigot (Author), L. Shannon Holliday (Author), Sihong Song (Author)
Format:	Book
Published:	BMC, 2017-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
by: Zi'ang Hu, et al.
Published: (2018)

Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways
by: Yu Yuan, et al.
Published: (2020)

Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation
by: Soni Ghumnani, et al.
Published: (2023)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
by: Jianbo He, et al.
Published: (2021)

Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity
by: Jianbo He, et al.
Published: (2023)

Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase
by: Jung-Yoon Choe, et al.
Published: (2015)

Osteoclast activity in osteoporosis mandibular bone based on RANKL and osteoprotegerin ratio.
by: Mefina Kuntjoro, et al.
Published: (2021)

CpG Oligodeoxynucleotides Inhibit RANKL-Induced Osteoclast Formation by Upregulating A20 Deubiquitinase in RAW 264.7 Cells
by: Seong-Kyu Kim, et al.
Published: (2022)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
by: Chuandong Wang, et al.
Published: (2017)

Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
by: Yu-Xi Li, et al.
Published: (2020)

The RANKL expression and osteoclast in alveolar bone of rat diabetic model at different mechanical force application
by: Nuzulul Hikmah, et al.
Published: (2018)

Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells
by: Eun-Nam Kim, et al.
Published: (2020)

Nrf2 Mitigates RANKL and M-CSF Induced Osteoclast Differentiation via ROS-Dependent Mechanisms
by: Yang Yang, et al.
Published: (2023)

Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis
by: Dianshan Ke, et al.
Published: (2022)

The Delivery of α1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore
by: Srinu Tumpara, et al.
Published: (2020)

Artemisinic acid attenuates osteoclast formation and titanium particle-induced osteolysis via inhibition of RANKL-induced ROS accumulation and MAPK and NF-κB signaling pathways
by: Tian Gao, et al.
Published: (2024)

Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease
by: Raafe Ghouse, et al.
Published: (2014)

Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis in Vivo and Inhibits RANKL-Induced Osteoclast Differentiation in Vitro
by: Qi Wang, et al.
Published: (2018)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
by: Eun-Jung Kim, et al.
Published: (2018)

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
by: Li X, et al.
Published: (2021)

Corrigendum: Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis In Vivo and Inhibits RANKL-Induced Osteoclast Differentiation In Vitro
by: Qi Wang, et al.
Published: (2020)

Proteomic profiling reveals α1-antitrypsin, α1-microglobulin, and clusterin as preeclampsia-related serum proteins in pregnant women
by: Te-Yao Hsu, et al.
Published: (2015)

Ac-SDKP Attenuates Activation of Lung Macrophages and Bone Osteoclasts in Rats Exposed to Silica by Inhibition of TLR4 and RANKL Signaling Pathways
by: Jin F, et al.
Published: (2021)

α-Linoleic Acid Enhances the Capacity of α1-Antitrypsin to Inhibit Lipopolysaccharide-Induced IL-1β in Human Blood Neutrophils
by: Nupur Aggarwal, et al.
Published: (2016)

Tea Polyphenols Inhibit Rat Osteoclast Formation and Differentiation
by: Yoshiomi Oka, et al.
Published: (2012)

CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis via Modulating RANKL and ROS Signaling Pathways
by: Jing Li, et al.
Published: (2022)

Genipin Inhibits RANKL-Induced Osteoclast Differentiation Through Proteasome-Mediated Degradation of c-Fos Protein and Suppression of NF-κB Activation
by: Chang Hoon Lee, et al.
Published: (2014)

Effect of TNF-α on osteocyte RANKL expression during orthodontic tooth movement
by: Aseel Marahleh, et al.
Published: (2021)

Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways
by: Cong Wang, et al.
Published: (2024)

A new method for measuring osteoclast formation by electrical impedance
by: Haruka Emori, et al.
Published: (2015)

Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio
by: Kaixian Yan, et al.
Published: (2020)

Erratum to: Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
by: Jeong-Mi Kim, et al.
Published: (2017)

Alpha-1 Antitrypsin Deficiency: Home Therapy
by: Anna Annunziata, et al.
Published: (2021)

Alpha 1-antitrypsin retention in an ectopic liver
by: Cathomas Gieri, et al.
Published: (2011)

Correlation of Low Levels of α-1 Antitrypsin and Elevation of Neutrophil to Lymphocyte Ratio with Higher Mortality in Severe COVID-19 Patients
by: Ghazaleh Shimi, et al.
Published: (2021)

Effect of Recombinant α1-Antitrypsin Fc-Fused (AAT-Fc) Protein on the Inhibition of Inflammatory Cytokine Production and Streptozotocin-Induced Diabetes
by: Siyoung Lee, et al.
Published: (2013)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
by: Sabina Janciauskiene, et al.
Published: (2018)

Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016)

Therapeutic potential of alpha-1 antitrypsin in human disease
by: Minsun Kim, et al.
Published: (2018)

Phillyrin Attenuates Osteoclast Formation and Function and Prevents LPS-Induced Osteolysis in Mice
by: Jing Wang, et al.
Published: (2019)